Teva Pharmaceutical Inds

ISIN US8816242098

 | 

WKN 883035

 

Overview

Quote

Description

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Show more Show less
Healthcare Biopharmaceuticals Other Biopharmaceuticals Israel

Chart

Add ETF for comparison
Show more chart settings

Financials

Key metrics

Market capitalisation, EUR 13,619.32 m
EPS, EUR -1.34
P/B ratio 2.84
P/E ratio -
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 15,263.08 m
Net income, EUR -1,515.21 m
Profit margin -9.93%

What ETF is Teva Pharmaceutical Inds in?

There are 88 ETFs which contain Teva Pharmaceutical Inds. All of these ETFs are listed in the table below. The ETF with the largest weighting of Teva Pharmaceutical Inds is the Harbor Health Care UCITS ETF Accumulating.

Performance

Returns overview

YTD -42.23%
1 month -18.58%
3 months -42.68%
6 months -25.90%
1 year -3.38%
3 years +31.38%
5 years +27.95%
Since inception (MAX) -73.22%
2024 +120.40%
2023 +5.06%
2022 +23.20%
2021 -11.22%

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 45.80%
Volatility 3 years 43.07%
Volatility 5 years 42.28%
Return per risk 1 year -0.07
Return per risk 3 years 0.22
Return per risk 5 years 0.12
Maximum drawdown 1 year -45.11%
Maximum drawdown 3 years -45.11%
Maximum drawdown 5 years -47.01%
Maximum drawdown since inception -88.97%

Rolling 1 year volatility

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.